U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.1% on Tuesday.

Shares of OppFi Inc (NYSE:OPFI) fell sharply in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.

OppFi reported quarterly earnings of 33 cents per share which missed the analyst consensus estimate of 45 cents per share. The company reported quarterly sales of $145.170 million which missed the analyst consensus estimate of $155.898 million.

OppFi shares dipped 18.4% to $7.16 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

  • Upwork Inc (NASDAQ:UPWK) shares dipped 19.8% to $7.88 in pre-market trading after posting second-quarter results.
  • Electrovaya Inc (NASDAQ:ELVA) slipped 16.4% to $7.72 in pre-market trading after the company reported third-quarter financial results. The company issued FY26 sales guidance below estimates.
  • ACV Auctions Inc (NYSE:ACVA) declined 15.7% to $6.12 in pre-market trading after the company reported worse-than-expected second-quarter financial results.
  • On Holding AG (NYSE:ONON) shares fell 15.4% to $32.80 in pre-market trading following second-quarter results.
  • Tactile Systems Technology Inc (NASDAQ:TCMD) shares dipped 12.5% to $25.51 in pre-market trading after the company reported second-quarter financial results and narrowed its FY26 sales guidance.
  • Rocket Lab Corp (NASDAQ:RKLB) shares declined 10.2% to $71.90 in pre-market trading following mixed quarterly results.
  • Entravision Communications Corp (NYSE:EVC) fell 9.6% to $10.58 in pre-market trading following second-quarter results.
  • Silvercorp Metals Inc (NYSE:SVM) dipped 9.2% to $11.09 in pre-market trading following first-quarter results.
  • Harrow Inc (NASDAQ:HROW) fell 9.1% to $37.00 in pre-market trading following quarterly results.
  • Olema Pharmaceuticals Inc (NASDAQ:OLMA) dipped 8.8% to $10.88 in pre-market trading following a wider-than-expected quarterly loss.
  • Hims & Hers Health Inc (NYSE:HIMS) fell 6.8% to $29.61 in pre-market trading after reporting mixed second-quarter results.

Photo via Shutterstock